The Drug Development Letter
Vinay Prasad, Aaron Goodman "Papa Heme", Timothée Olivier, Alyson HaslamWe cover all aspects of pharmaceutical drug development; early, late phase and FDA pivotal trials; Focus on oncology, but also cover important cardiology, neurology and drugs for rare diseases
| Platform |  | Pricing | Freemium | Publishes | Twice weekly |
|---|---|---|---|---|---|
| Issues | 31 | Subscribers | Read | developdrugs.substack.com |
Curious about how many subscribers The Drug Development Letter has or want to find similar newsletters? Reletter has got you covered. We collated all the information we could find from across the web in our database of over one million newsletters.
Check the email archives, get traffic estimates, engagement scores and more to discover the best advertising opportunities.
Our search tool helps you locate relevant newsletters for any topic and compare their stats for better sponsorship decisions.
Chart Rankings
How this newsletter ranks in the official Substack charts.
| #192 |
Latest Issues
Recent posts by this newsletter. Browse the email archive.
How many people benefit from CAR-T?
Chimeric antigen receptor (CAR)-T therapies are a group of novel cancer treatment options that have generated a lot of excitement because of high response rates and durable remissions in some individuals. Currently, they are only approved f...
Ash Update with Aaron Goodman
My UK myeloma talk
Observational studies and randomized trials
Wanted to make my lecture available to the audience of the drug development letter
Authors
The writers behind this newsletter.
Hematology more
I am a guitar playing hematologist/bone marrow transplanter who enjoys educating trainees!
Medical oncologist based in Geneva University Hospital (Switzerland), I joined Vinay Prasad's research lab (@vkprasadlab) at University of California San Francisco (UCSF) in November 2021.
Health policy researcher at UCSF
Frequently Asked Questions
How can I access the email archive for The Drug Development Letter?
You can find recent issues that have been published by The Drug Development Letter on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does The Drug Development Letter have?
To see how many people subscribe to The Drug Development Letter, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in The Drug Development Letter?
Newsletter advertising can be extremely effective when it's done right. Before you pitch The Drug Development Letter as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like The Drug Development Letter?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact The Drug Development Letter using the contact information provided and ask for a copy of their media kit.
How can I find newsletters similar to The Drug Development Letter?
Scroll up to where it says Similar Newsletters to see other publications like The Drug Development Letter. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact The Drug Development Letter?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.